ID: ALA1171000

Max Phase: Preclinical

Molecular Formula: C15H25N

Molecular Weight: 219.37

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  CCC1CCC2(N1)C1CC3CC(C1)CC2C3

Standard InChI:  InChI=1S/C15H25N/c1-2-14-3-4-15(16-14)12-6-10-5-11(8-12)9-13(15)7-10/h10-14,16H,2-9H2,1H3

Standard InChI Key:  JJOUOPDSZFMWGO-UHFFFAOYSA-N

Associated Targets(non-human)

Matrix protein 2 436 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 219.37Molecular Weight (Monoisotopic): 219.1987AlogP: 3.34#Rotatable Bonds: 1
Polar Surface Area: 12.03Molecular Species: BASEHBA: 1HBD: 1
#RO5 Violations: 0HBA (Lipinski): 1HBD (Lipinski): 1#RO5 Violations (Lipinski): 0
CX Acidic pKa: CX Basic pKa: 12.19CX LogP: 3.25CX LogD: 0.02
Aromatic Rings: 0Heavy Atoms: 16QED Weighted: 0.71Np Likeness Score: 1.09

References

1. Eleftheratos S, Spearpoint P, Ortore G, Kolocouris A, Martinelli A, Martin S, Hay A..  (2010)  Interaction of aminoadamantane derivatives with the influenza A virus M2 channel-docking using a pore blocking model.,  20  (14): [PMID:20570509] [10.1016/j.bmcl.2010.05.049]

Source